Back

A survey of availability and affordability of polypills for primary and secondary prevention of cardiovascular diseases in selected countries

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Exploring cardiovascular health: environmental exposures, treatment disparities, and lifestyle influences Public Health ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Gautam Satheesh

George Institute for Global Health, Hyderabad (India)

7 More presentations in this session

Presentation thumbnail
What does routine healthcare data tell us about the diagnostic pathway for older people with heart failure in Wales: under-testing, problems with access, or poor coding?
Doctor E. Rees (Swansea, GB)
Abstract Slides Video
Presentation thumbnail
All-cause, cancer and cardiovascular mortality among South Asians living in the UK: Follow-up of the London Life Sciences Population (LOLIPOP) cohort
Doctor I. Kooner (London, GB)
Abstract Slides Video
Presentation thumbnail
Differences in treatment and outcome of patients with ST- Elevation Myocardial Infarction (STEMI) and Non-STEMI in Germany
Doctor S. Lange (Munster, DE)
Abstract Slides Video
Presentation thumbnail
A data-driven framework for the definition of heat in CV research for better comprehension of climate changes on human health
Professor E. Caiani (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Cardiovascular mortality rate between 2018 and 2022 in Kyrgyz Republic
Doctor A. Abdurasulova (Bishkek, KG)
Abstract Slides Video

Access the full session

Session thumbnail
Exploring cardiovascular health: environmental exposures, treatment disparities, and lifestyle influences

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Polypill and atherothrombosis
thumbnail
Congress Presentation
The cardiovascular polypill strategy (acetyl salicylic acid, atorvastatin, ramipril) as baseline treatment after a cardiovascular event supported by compelling evidence: a global expert consensus
thumbnail
Congress Session
Cardiovascular drug adherence and persistence: relevance and implementation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources